default author photo

Leonard B. Saltz

Memorial Sloan Kettering Cancer Center

New York, NY 10065

United States

SCHOLARLY PAPERS

1

DOWNLOADS

61

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Treatment and Survival Outcomes by Age Following Second-Line Therapy for Metastatic CRC (mCRC): Analysis of 13,149 Patients from the ARCAD Clinical Trials Program

Number of pages: 28 Posted: 08 Feb 2021
Harvard University - Dana-Farber Cancer Institute, Mayo Clinic - Department of Health Science Research, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Monash University, Cardiff University and Velindre Cancer Centre, West Cancer Center and Research Institute, Ospedale San Martino - Medical Oncology Unit, KU Leuven, West Virginia University Cancer Institute and the Mary Babb Randolph Cancer Center, University of Antwerp - Multidisciplinary Oncologic Centre Antwerp (MOCA), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, University of Leeds - Institute of Oncology, Memorial Sloan Kettering Cancer Center, University of Pennsylvania Perelman School of Medicine - Abramson Cancer Center, Instituto CUF de Oncologia, Pfizer, Inc. - Global Product Development, University Medical Center Utrecht - Department of Medical Oncology, Martin Luther University, Mayo Clinic - Department of Oncology, University of São Paulo (USP) - Instituto do Cancer do Estado de Sao Paulo, University of Sydney Medical School, University of Pisa - Department of Oncology, University General Hospital of Heraklion - Department of Medical Oncology, Universitatsklinikum Hamburg-Eppendorf, LMU Munich - Department of Hematology/Oncology, National Cancer Center Hospital East, Institut Franco-Britannique - Department of Medical Oncology, Institut Franco-Britannique - Department of Medical Oncology, Mayo Clinic - Department of Health Science Research and NIHR Clinical Research Network, Leeds
Downloads 61 (951,658)

Abstract:

Loading...